Search Results - "De Geer, W.S."

31P Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma by Joode, K.D., van de Geer, W.S., van Leenders, G.J.L.H., Hamberg, P., Westgeest, H.M., Beeker, A., Oosting, S.F., van Rooijen, J.M., Beerepoot, L.V., Labots, M., Mathijssen, R.H., Lolkema, M.P., Cuppen, E., Sleijfer, S., van de Werken, H.J.G., Van der Veldt, A.A.M.

Get full text

Cabazitaxel efficacy is strongly enhanced by continued Androgen Receptor Targeted Agents (ARTA) in Castration-Resistant Prostate Cancer (CRPC) by Mout, L., Van Royen, M.E., De Ridder, C.M.A., Stuurman, D., Marques, R.B., De Geer, W.S., Van De Werken, H.J.G., Mathijssen, R.H.J., De Wit, R., Lolkema, M.P., Van Weerden, W.M.

Get full text

Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients by Bins, S., van de Geer, W.S., van Riet, J., Steeghs, N., Verheul, H.M.W., van Herpen, C., Witteveen, P.O., Tjan-Heijnen, V.C.G., Lolkema, M.P., Voest, E.E., Sleijfer, S., Cuppen, E., van de Werken, H.J.G., Mathijssen, R.H.J.

Get full text

100P - Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients by Bins, S., van de Geer, W.S., van Riet, J., Steeghs, N., Verheul, H.M.W., van Herpen, C., Witteveen, P.O., Tjan-Heijnen, V.C.G., Lolkema, M.P., Voest, E.E., Sleijfer, S., Cuppen, E., van de Werken, H.J.G., Mathijssen, R.H.J.

“…Systemic anti-cancer treatment is hampered by drug resistance (DR). However, little is known about the pharmacokinetic consequences of genetic changes in tumor…”
Get full text